Wolff Henry Ward 4
4 · SUNESIS PHARMACEUTICALS INC · Filed Jul 3, 2018
Insider Transaction Report
Form 4
Wolff Henry Ward
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-29+6,250→ 6,250 totalExercise: $2.12Exp: 2028-06-29→ Common Stock (6,250 underlying) - Award
Stock Option (Right to Buy)
2018-02-28+37,500→ 37,500 totalExercise: $6.80Exp: 2028-02-28→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]The option shall vest and become exercisable in twenty-four (24) equal monthly installments over a two (2) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
- [F2]The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.